Literature DB >> 15023508

Substance use and perceived symptom improvement among patients with bipolar disorder and substance dependence.

Roger D Weiss1, Monika Kolodziej, Margaret L Griffin, Lisa M Najavits, Lara M Jacobson, Shelly F Greenfield.   

Abstract

BACKGROUND: Bipolar disorder (BPD) is the Axis I disorder with the highest risk for coexisting substance use disorder. One explanation for this phenomenon is the 'self-medication hypothesis', which states that some patients experience improvement in psychiatric symptoms as a result of substance use. We thus investigated reasons for substance use and perceived substance-induced improvement in BPD symptoms among patients with current BPD and substance dependence.
METHODS: A total of 45 patients received six monthly assessments; 21 also received integrated group therapy (IGT), focusing simultaneously on BPD and substance dependence, while 24 did not receive IGT. Patients reported at intake their current reasons for initiating substance use (including BPD symptoms) and the effects of substance use on those symptoms.
RESULTS: Nearly all patients initiated substance use because of at least one BPD symptom, especially depression (77.8%) and racing thoughts (57.8%); most (66.7%) reported improvement in at least one BPD symptom as a result of substance use. Among patients reporting substance-induced improvement in BPD symptoms, those receiving IGT reported fewer days of drug use over the 6-month study period than those not receiving IGT; this difference was not significant among patients without substance-induced improvement in BPD symptoms. LIMITATIONS: The study is limited by its small sample size and by the potential inaccuracy of self-reports regarding the effects of substance use on mood.
CONCLUSIONS: Substance dependent patients who report that substance use improves their BPD symptoms may benefit from treatment that focuses simultaneously on both disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15023508     DOI: 10.1016/S0165-0327(02)00454-8

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  18 in total

1.  Dazed and confused by self-medication.

Authors:  R Andrews Chambers
Journal:  Am J Psychiatry       Date:  2010-05       Impact factor: 18.112

2.  Treatment development and feasibility study of family-focused treatment for adolescents with bipolar disorder and comorbid substance use disorders.

Authors:  Benjamin I Goldstein; Tina R Goldstein; Katelyn A Collinger; David A Axelson; Oscar G Bukstein; Boris Birmaher; David J Miklowitz
Journal:  J Psychiatr Pract       Date:  2014-05       Impact factor: 1.325

3.  Self-medication of mood and anxiety disorders with marijuana: Higher in states with medical marijuana laws.

Authors:  Aaron L Sarvet; Melanie M Wall; Katherine M Keyes; Mark Olfson; Magdalena Cerdá; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2018-03-02       Impact factor: 4.492

4.  Comorbid disorders in patients with bipolar disorder and concomitant substance dependence.

Authors:  Joshua D Mitchell; E Sherwood Brown; A John Rush
Journal:  J Affect Disord       Date:  2007-02-08       Impact factor: 4.839

5.  Reasons for substance use among adolescents with bipolar disorder.

Authors:  Boris Lorberg; Timothy E Wilens; Marykate Martelon; Patricia Wong; Tiffany Parcell
Journal:  Am J Addict       Date:  2010-09-21

6.  Temporal sequencing of nicotine dependence and bipolar disorder in the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

Authors:  José M Martínez-Ortega; Benjamin I Goldstein; Luis Gutiérrez-Rojas; Regina Sala; Shuai Wang; Carlos Blanco
Journal:  J Psychiatr Res       Date:  2013-04-11       Impact factor: 4.791

7.  Affective temperaments in alcohol and opiate addictions.

Authors:  Yasser Khazaal; Marianne Gex-Fabry; Audrey Nallet; Béatrice Weber; Sophie Favre; Raphael Voide; Daniele Zullino; Jean-Michel Aubry
Journal:  Psychiatr Q       Date:  2013-12

8.  Measuring principal substance of abuse in comorbid patients for clinical research.

Authors:  Margaret L Griffin; Monika E Kolodziej; Roger D Weiss
Journal:  Addict Behav       Date:  2009-03-06       Impact factor: 3.913

9.  Impact of remitted substance use disorders on the future course of bipolar I disorder: findings from a clinical trial.

Authors:  Brandon A Gaudiano; Lisa A Uebelacker; Ivan W Miller
Journal:  Psychiatry Res       Date:  2008-06-02       Impact factor: 3.222

Review 10.  Integrated treatment of substance use and psychiatric disorders.

Authors:  Thomas M Kelly; Dennis C Daley
Journal:  Soc Work Public Health       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.